Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Merck
McKesson
Johnson and Johnson
Express Scripts

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Alisporivir


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Alisporivir?

Alisporivir is an investigational drug.

There have been 15 clinical trials for Alisporivir. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2012.

The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, and Hepatitis A. The leading clinical trial sponsors are Debiopharm International SA, Parexel, and Enanta Pharmaceuticals.

There are four hundred and thirteen US patents protecting this investigational drug and six international patents.

Recent Clinical Trials for Alisporivir
TitleSponsorPhase
Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)Debiopharm International SAPhase 2
Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)Assistance Publique - Hôpitaux de ParisPhase 2
Two-way Interaction Between Alisporivir and EDP239Enanta PharmaceuticalsPhase 1

See all Alisporivir clinical trials

Clinical Trial Summary for Alisporivir

Top disease conditions for Alisporivir
Top clinical trial sponsors for Alisporivir

See all Alisporivir clinical trials

US Patents for Alisporivir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Alisporivir ⤷  Try it Free 1',4'-thio nucleosides for the treatment of HCV IDENIX PHARMACEUTICALS LLC (Cambridge, MA) ⤷  Try it Free
Alisporivir ⤷  Try it Free Benzimidazole derivatives Enanta Pharmaceuticals, Inc. (Watertown, MA) ⤷  Try it Free
Alisporivir ⤷  Try it Free Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (Atlanta, GA) ⤷  Try it Free
Alisporivir ⤷  Try it Free Anti-viral compounds AbbVie Inc. (North Chicago, IL) ⤷  Try it Free
Alisporivir ⤷  Try it Free Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1',2':4,5]pyrazino[1,2-a][- 1,3]diazepines and methods for treating viral infections GILEAD SCIENCES, INC. (Foster City, CA) ⤷  Try it Free
Alisporivir ⤷  Try it Free Use of solid carrier particles to improve the processability of a pharmaceutical agent Gilead Sciences, Inc. (Foster City, CA) ⤷  Try it Free
Alisporivir ⤷  Try it Free Anti-viral compounds AbbVie Inc. (North Chicago, IL) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Alisporivir

Drugname Country Document Number Estimated Expiration Related US Patent
Alisporivir World Intellectual Property Organization (WIPO) WO2015077368 2033-11-22 ⤷  Try it Free
Alisporivir World Intellectual Property Organization (WIPO) WO2012048170 2030-10-06 ⤷  Try it Free
Alisporivir European Patent Office EP3004130 2033-06-05 ⤷  Try it Free
Alisporivir World Intellectual Property Organization (WIPO) WO2014197578 2033-06-05 ⤷  Try it Free
Alisporivir Australia AU2010217797 2029-02-27 ⤷  Try it Free
Alisporivir Brazil BRPI1007836 2029-02-27 ⤷  Try it Free
Alisporivir Canada CA2753382 2029-02-27 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Merck
McKesson
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.